Seoudi H, Mortier J, Basile R, Curletti E
Department of Surgery, University of Massachusetts Medical School, Berkshire Medical Center, Pittsfield 01201, USA.
Arch Surg. 1998 Apr;133(4):366-72. doi: 10.1001/archsurg.133.4.366.
To evaluate the correlation between the pathological findings of stereotactic core needle biopsy (SCNB) and the prebiopsy mammographic findings, as well as the pathological findings of lesions that were subsequently removed by surgical excision.
A retrospective review of 97 consecutive patients who underwent 100 SCNBs of suspicious nonpalpable mammographic lesions. The criterion standard is surgical excisional biopsy with needle localization. Mammographic findings were graded according to the American College of Radiology Breast Imaging Reporting and Data System. The pathological findings of SCNB were categorized into 4 groups: benign and specific, benign and nonspecific, premalignant, and malignant. Surgical excision of the lesion was performed if the pathological finding on SCNB was nonconcordant with the prebiopsy mammogram and when premalignant or malignant lesions were found. The pathological findings of lesions that were subsequently removed by surgical excision were compared with those of SCNB.
Community-based private multispecialty ambulatory practice.
A population-based sample composed of 97 patients who had grade III, IV, or V lesions on routine screening mammograms.
Stereotactic core needle biopsy of nonpalpable mammographic lesions.
Percentage of patients whose SCNB results were concordant with the mammographic findings and the pathological findings on subsequent surgical excision.
Concordance between SCNB and mammography occurred in 97% of biopsy specimens. Concordance between the pathological findings of SCNB and those of surgically excised lesions occurred in 92.5% of biopsy specimens. We had 1 false-negative result. We had no false-positive diagnosis of cancer with SCNB.
On the basis of accumulating literature and our own initial experience, SCNB is a promising, safe, and cost-effective procedure.
评估立体定向真空辅助活检(SCNB)的病理结果与活检前乳腺钼靶检查结果之间的相关性,以及随后通过手术切除的病变的病理结果。
对97例连续接受100次SCNB检查的可疑不可触及乳腺钼靶病变患者进行回顾性研究。标准对照为带针定位的手术切除活检。乳腺钼靶检查结果根据美国放射学会乳腺影像报告和数据系统进行分级。SCNB的病理结果分为4组:良性且有特异性、良性且无特异性、癌前病变和恶性病变。如果SCNB的病理结果与活检前乳腺钼靶检查结果不一致,以及发现癌前病变或恶性病变时,则对病变进行手术切除。将随后通过手术切除的病变的病理结果与SCNB的结果进行比较。
社区私立多专科门诊。
以人群为基础的样本,由97例在常规筛查乳腺钼靶检查中发现III级、IV级或V级病变的患者组成。
对不可触及的乳腺钼靶病变进行立体定向真空辅助活检。
SCNB结果与乳腺钼靶检查结果一致的患者百分比,以及随后手术切除时的病理结果。
97%的活检标本中SCNB与乳腺钼靶检查结果一致。92.5%的活检标本中SCNB的病理结果与手术切除病变的病理结果一致。有1例假阴性结果。SCNB未出现癌症的假阳性诊断。
基于积累的文献和我们自己的初步经验,SCNB是一种有前景、安全且具有成本效益的检查方法。